About Ambrons Pharma Private Limited
Data last updated:
Ambrons Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 14 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2015PTC275414. Its GSTIN is 09AANCA1561C1ZV (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Balbir Singh and Anil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 14 Pocket – A Ground Floor Csc Market Sukhdev Vihar, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2022, the company reported a revenue of ₹36.61 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹32,648 (net margin 0.9%) and EBITDA of ₹45,375 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years and 33% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website ambrons.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address14 Pocket – A Ground Floor Csc Market Sukhdev Vihar, New Delhi, Delhi, India – 110025
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ambrons Pharma Private Limited
The main business activity of Ambrons Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ambrons Pharma Private Limited FY 2022 filings available
Ambrons Pharma Private Limited reported revenue of ₹36.61 Lakh (down 11% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Ambrons Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 33% over five years, including a 11% fall in the latest year. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ambrons Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹45,375 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹32,648 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ambrons Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ambrons Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ambrons Pharma Private Limited
Ambrons Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Redwood Herbals Private Limited | ₹36.62 Lakh (FY 2024) | •••• | •••• | 68.0% | •••• | Delhi, India |
| J.S.Pvt Ltd | ₹36.62 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Kolkata, West Bengal, India |
| Dettago Private Limited | ₹36.62 Lakh (FY 2025) | •••• | •••• | -44.0% | •••• | Nilambur, Kerala, India |
| Kuldeep Impex Private Limited | ₹36.61 Lakh (FY 2024) | •••• | •••• | -79.0% | •••• | Jaipur, Rajasthan, India |
| Karwa Exports Private Limited | ₹36.61 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Uttar Pradesh, India |
| Ambrons Pharma Private Limited this company | ₹36.61 Lakh (FY 2022) | •••• | •••• | -11.0% | •••• | New Delhi, Delhi, India |
| V.K. Sulz Private Limited | ₹36.61 Lakh (FY 2017) | •••• | •••• | 130.0% | •••• | Bhilwara, Rajasthan, India |
| Nextee Trade Private Limited | ₹36.6 Lakh (FY 2024) | •••• | •••• | •••• | Gurugram, Haryana, India | |
| Bhilwara Farmer Producer Company Limited | ₹36.58 Lakh (FY 2019) | •••• | •••• | 5357.0% | •••• | Bhilwara, Rajasthan, India |
| Saiko No Torihiki Private Limited | ₹36.56 Lakh (FY 2025) | •••• | •••• | -85.0% | •••• | Bhiwadi, Rajasthan, India |
| Lumos Drugs & Surgical Private Limited | ₹36.56 Lakh (FY 2025) | •••• | •••• | 137.0% | •••• | Guwahati, Assam, India |
Peers are the five companies nearest above and the five nearest below Ambrons Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ambrons Pharma Private Limited
Ambrons Pharma Private Limited is audited by MANOJ USHA & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANOJ USHA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ambrons Pharma Private Limited
Ambrons Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balbir Singh | Director | 14 Jan 2015 | 11 Years 8 Months | Current |
| Anil Kumar | Director | 14 Jan 2015 | 11 Years 8 Months | Current |
| Sunil Kumar Also directs: Biosalt Pharmaceuticals LLP, Emsense Biosciences Private Limited | Director | 14 Jun 2019 | 7 Years 3 Months | Current |
Ownership and Shareholding of Ambrons Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ambrons Pharma Private Limited
Ambrons Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ambrons Pharma Private Limited
Employment history and EPFO contributions of people linked to Ambrons Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ambrons Pharma Private Limited
Ambrons Pharma Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Sunil Kumar was appointed as Director on 14 Jun 2019.
Credit Ratings, Litigation & Regulatory Alerts for Ambrons Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ambrons Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ambrons Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ambrons Pharma Private Limited
Ambrons Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCA1561C1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ambrons Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambrons Pharma Private Limited
Ambrons Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 14 January 2015 (11+ years old) and is registered under CIN U74140DL2015PTC275414.
Ambrons Pharma reported revenue of ₹36.61 Lakh for FY 2022 (down 11% YoY).
Ambrons Pharma has 3 current directors:
- Balbir Singh - Director
- Anil Kumar - Director
- Sunil Kumar - Director
Ambrons Pharma reported a net profit of ₹32,648 (net margin 0.9%) and EBITDA of ₹45,375 (EBITDA margin 1.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ambrons Pharma is 44% over three years and -33% over five years. In the latest year (FY 2022) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ambrons Pharma is 09AANCA1561C1ZV, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ambrons Pharma is U74140DL2015PTC275414. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambrons Pharma was incorporated on 14 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ambrons Pharma by revenue are Redwood Herbals Private Limited, J.S.Pvt Ltd, Dettago Private Limited, Kuldeep Impex Private Limited, Karwa Exports Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Sunil Kumar was appointed as Director on 14 Jun 2019. Anil Kumar was appointed as Director on 14 Jan 2015. Balbir Singh was appointed as Director on 14 Jan 2015.
Yes, Ambrons Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).